Our knowledge of the transformation process has emerged largely from studies of primary rodent cells and animal models. However, numerous attempts to transform human cells using oncogene combinations that are effective in rodents have proven unsuccessful. These findings strongly argue for the study of homologous experimental systems. Here we report that the combined expression of adenovirus E1A, Ha-RasV12, and MDM2 is sufficient to convert a normal human cell into a cancer cell. Notably, transformation did not require telomerase activation. Therefore, we provide evidence that activation of telomere maintenance strategies is not an obligate characteristic of tumorigenic human cells.
Introduction
O 'Brien et al., 1986; Stevenson and Volsky, 1986; Serrano et al., 1997) . Two major hypotheses have emerged as the underlying exNeoplastic transformation occurs via a series of genetic and planation for such differences. Primary human and murine cells epigenetic alterations that yield a cell population that is capable respond to oncogene activation via homeostatic mechanisms of proliferating independently of both external and internal sigthat are proposed to enforce tumor suppression. For example, nals that normally restrain growth. For example, transformed activation of oncogenes such as c-myc or adenovirus E1A sensicells show reduced requirements for extracellular growth protizes primary cells to apoptosis (Debbas and White, 1993; Lowe moting factors, are not restricted by cell-cell contact, and are et al., 1994; Lowe and Ruley, 1993; Harrington et al., 1994; often immortal (Paulovich et al., 1997; Hanahan and Weinberg, Hermeking and Eick, 1994) . Hyperactivation of the ras oncogene 2000) . Through extensive studies of transformation processes or flux through the ras signaling pathway induces a state of in rodent models, it is known that tumor formation can be terminal growth arrest which is phenotypically similar to cellular achieved by the activation of oncogenes and the inactivation senescence (Serrano et al., 1997) . In murine cells, the latter of tumor suppressor pathways (Paulovich et al., 1997; Hanahan response can be bypassed by genetic alterations, which impair and Weinberg, 2000; Sherr, 1996) . It has long been established the p53 response. Indeed, cells lacking p53 or p19 ARF can be that primary rodent cells can be transformed at detectable fretransformed directly by activated ras (Kamijo et al., 1997 ; Serquency by two oncogenic "hits," such as the combination of rano et al., 1996, 1997) . In contrast, inactivation of the p53 ectopic c-myc expression and constitutive activation of Harvey pathway alone is insufficient to rescue human cells from rasRas (Ha-RasV12) (Land et al., 1983; Ruley, 1983) . However, induced growth arrest (Serrano et al., 1997) , suggesting that primary human cells have proven to be refractory to transformahomeostatic responses in humans flow through multiple indetion by numerous combinations of cellular and viral oncoprotpendent and redundant effector pathways. eins, indicative of fundamental differences in requirements for A second characteristic that distinguishes primary human and murine cells is that the latter are easily immortalized (Blasco transformation in human versus rodent cells (Sager, 1991; et al., 1997a) . Primary human cells rarely undergo spontaneous the adenovirus oncogene, E1A ( Figure 1A ) (Serrano et al., 1997; de Stanchina et al., 1998) . In fact, coexpression of E1A and Haimmortalization, indicating that the control of cellular lifespan is RasV12 provided one of the first demonstrations of transformadrastically different between these two cell types (Imam et al., tion by cooperating oncogenes in primary rodent cells (Ruley, 1997; Chin et al., 1999) . This phenomenon can be partially attrib-1983 ). Therefore, we tested whether combined expression of uted to telomere biology. Unlike the embryonic rodent fibro-E1A and Ha-RasV12 could transform normal human primary blasts which have served as common models for studies of fibroblasts. transformation in vitro, primary human fibroblasts have relatively One characteristic feature of transformed cells is their ability short telomeres and lack detectable telomerase activity (reto grow in the absence of anchorage and, therefore, form coloviewed in McEachern et al., 2000) .
nies in semisolid media. Early passage normal human foreskin The importance of telomerase in human tumorigenesis is fibroblasts (designated BJ) expressing E1A or Ha-RasV12 indisupported by numerous observations. First, the majority of huvidually failed to form colonies in soft agar. In contrast, cells man tumors are telomerase-positive (Kim et al., 1994) . Second, expressing both E1A and Ha-RasV12 were able to form colonies telomerase activation is sufficient to immortalize some primary in soft agar with an efficiency comparable to that seen with human cells in culture (Bodnar et al., 1998; Counter et al., 1998;  transformed human and rodent cells ( Figure 1B ). For human Wang et al., 1998) . Third, telomerase is regulated by an onco-293T cells, virtually all plated cells gave rise to colonies, comgene, c-myc, which is activated in a high percentage of human pared to a range of 10%-30% for BJ/E1A/Ha-RasV12 (for examcancers .
ple, see Figure 1C ). In general, colonies generated by BJ/ER Previous reports have indicated that primary human fibro-(EϭE1A, RϭHa-RasV12) contain significantly fewer cells than blasts and epithelial cells can be transformed by a defined comthose generated by 293T cells within the same time period. bination of genetic elements, comprising the telomerase catalytic subunit, hTERT, the SV40 early region, and Ha-RasV12
The role of E1A in the transformation of primary (Hahn et al., 1999; Elenbaas et al., 2001 , Hahn et al., 2002 . Here human fibroblasts we report an alternative model of human cell transformation. We E1A is a multifunctional protein that interacts with numerous show that coexpression of two oncogenes, adenovirus E1A and cellular proteins involved in controlling proliferation. For examHa-RasV12, is sufficient to enable primary human fibroblasts ple, E1A can bind members of the Rb family through conserved to grow in an anchorage-independent manner, a hallmark of in motifs designated CR1 and CR2 (Whyte et al., 1988; Harlow et vitro transformation. However, this combination is insufficient al., 1986; Whyte et al., 1989) . Through these interactions, E1A to promote tumor formation in nude mice. Addition of a third is able to modulate the activity of the E2F family of transcription oncogene, MDM2, can convert these fibroblasts into cells capafactors, thus controlling genes required for entry into S phase (Wang et al., 1995; Paulovich et al., 1997; Sherr, 1996) . The ble of forming tumors in vivo. Interestingly, both anchorageamino-terminus of E1A binds promiscuous transcriptional coindependent growth in vitro and tumorigenesis in vivo occur in activators, including p300 (Dorsman et al., 1995; Wang et al. , the absence of telomerase activation. Our results indicate that 1995; Goodman and Smolik, 2000) . The amino-terminus also while telomerase activation is a common characteristic of hubinds to the protein complex containing p400, a SWI2/SNF2 man tumors, it is not an obligate element of the tumorigenic family member, and the c-Myc/pCAF-interacting protein, phenotype.
TRRAP (McMahon et al., 1998; Barbeau et al., 1994 , Fuchs et al., 2001 ). This p400 binding region has been shown to be vital Results for E1A-mediated transformation in mouse cells (Fuchs et al., 2001) . The carboxy-terminal region of E1A binds CtBP, a cellular Coexpression of E1A and Ha-RasV12 permits protein, which has been proposed to recruit histone deacetyanchorage-independent growth lases (Goodman and Smolik, 2000) . A defining characteristic of the transformed phenotype is a deIn order to map the regions and interactions of E1A that are gree of independence from exogenous mitogenic signals. Many essential for its ability to cooperate with Ha-RasV12 in conferring of these signals activate the ras pathway, and activating mutaanchorage-independent growth to primary human fibroblasts, tions of ras oncogenes or their upstream regulators often occur we used a series of well-characterized deletion mutants for in in human cancers (Barbacid, 1987; Webb et al., 1998) . However, vitro transformation assays (Samuelson and . Cells in both primary rodent and human cells, expression of the ras were coinfected with Ha-RasV12 and mutant E1A oncoproteins. oncogene alone results in an irreversible growth arrest that is While a truncated E1A protein consisting of only the aminophenotypically similar to cellular senescence (Serrano et al., terminal 143 amino acids is unable to bind CtBP (Boyd et al., 1997; Lin et al., 1998) . In rodent models, c-myc is capable of 1993; Meloni et al., 1999) , this mutant is capable of cooperating both bypassing ras-induced growth arrest and cooperating with with Ha-RasV12 for colony formation in soft agar with high activated Ha-RasV12 to transform primary cells into tumorigenic efficiency (Figure 2 ). Expression of E1A-⌬CR2, a mutant incapacells (Land et al., 1983) . However, combined expression of myc ble of binding pRb (Samuelson and Lowe, 1997) , in combination and activated ras in normal human cells not only fails to result with Ha-RasV12 invariably led to a senescence-like growth arin transformation, but also leads to an accelerated appearance rest. This result indicated that the interaction between E1A and of the senescent-like phenotype (data not shown).
Rb-family proteins is essential for transformation. Loss of the Whereas numerous genetic alterations have been shown to ability to bind p300 also compromised oncogene cooperation, bypass ras-induced growth arrest in murine cells, only very few as did deletion of residues 26-35, indicating that the ability to have been shown to be capable of overriding this response in bind p400 is also critical. Western analysis of E1A mutants (Supplemental Figure S1 at http://www.cancercell.org/cgi/ normal human cells. One of these is the ectopic expression of A: Normal human diploid fibroblasts (BJ) infected with a recombinant retrovirus that directs expression of Ha-RasV12 stain positively for expression of the senescence-associated ␤-galactosidase marker, whereas BJ fibroblasts coinfected with retroviruses for E1A (12s) and Ha-RasV12 expression do not stain for this marker and continue to proliferate. B: BJ fibroblasts were infected with retroviruses for E1A or Ha-RasV12 expression alone or in combination and assayed for colony formation in semisolid media. C: Colonies containing greater than 100 cells were counted from triplicate platings of cells with the indicated genotype to determine the rate of colony formation. Standard error from the mean is indicated.
content/full/2/5/401/DC1) suggested that each was expressed subcutaneous injection into immunocompromised mice. A total of 49 animals were injected in both flanks in a series of five similarly to wild-type, and thus the defects in colony formation independent experiments. Subject mice were either nude, SCID were not due to E1A not being adequately expressed. Expres-(beige), or nude mice that had been irradiated as a mean to sion of E1A-⌬CR2 mutant was confirmed only in transient infecsuppress residual NK (natural killer) responses (Feuer et al., tions, since the prevalence of cell death in ⌬CR2/Ras coinfected 1995). From a total of 98 injections, only a single tumor formed cells prevented the establishment of a stable cell line. Considin a nude, nonirradiated mouse (Supplemental Table S1 at http:// ered together, these results suggest that E1A functions in human www.cancercell.org/cgi/content/full/2/5/401/DC1). This tumor cell transformation through concerted effects on multiple cellular arose after a substantially longer latency (10 weeks) than is pathways that include Rb, p300, and p400.
normally observed using control cancer cell lines or transformed human 293T cells ‫2ف(‬ weeks), suggesting the possibility that a E1A ϩ Ha-RasV12-expressing cells fail to form tumors Early and late passage BJ fibroblasts coexpressing E1A and rare additional genetic alteration may have contributed to tumor formation in this individual case. Thus, we conclude that while Ha-RasV12 were tested for the ability to form tumors upon A series of well-characterized functional mutants of E1A were coexpressed in BJ fibroblasts with Ha-RasV12 and assayed for the ability to form colonies in semisolid media. Only the E1A-143 mutant, which is defective for the ability to bind CtBP, was capable of forming colonies in this assay, indicating that the ability of E1A to bind p300, p400, and Rb is critical for E1A-mediated transformation.
the combination of E1A and Ha-RasV12 is sufficient to permit anchorage-independent growth of normal human fibroblasts, this combination is insufficient for tumorigenesis in nude mice.
E1A, MDM2, and Ha-RasV12 transform normal human cells into tumor cells
Previous studies of E1A/Ha-RasV12-mediated transformation in primary mouse embryo fibroblasts (MEF) indicated that transformation mediated by this oncogene combination was much more efficient in the absence of p53 (Lowe and Ruley, 1993) . In fact, tumors arising from E1A/Ras transformed MEF become apparent only after a long latency period and frequently lack a functional p53 pathway. Interestingly, immunohistochemical analysis of the single tumor produced by the BJ fibroblasts expressing E1A/Ha-RasV12 showed a strong accumulation of nuclear p53; however, results of SSCP analysis excluded the possibility of p53 gene mutations (data not shown).
Accumulation of wild-type p53 is a common feature of human sarcoma, the type of tumor derived from fibroblast precursors. In addition, these tumors often show overexpression of MDM2 (Dei Tos et al., 1997) , indicating that negation of p53 function occurs often through mechanisms other than p53 gene mutation. Notably, the tumor that resulted from the E1A/ Ha-RasV12-expressing fibroblasts was negative for the expression of p19 ARF , an upstream regulator of MDM2 (by immunohistochemistry, data not shown), whereas the preinjection population of engineered fibroblasts expressed p19 ARF abundantly. Guided by these observations, we tested whether negation of the p53 pathway via enforced expression of MDM2 could contribute to the transformation of normal human fibroblasts by E1A and HaRasV12.
BJ cells at different passage numbers (see Experimental firmed by Western blot (not shown). Cell populations expressing E1A/Ha-RasV12/MDM2 formed colonies in soft agar with higher efficiency than BJ/E1A/Ha-RasV12 ( Figure 3B ). Moreover, the triple-infected cells were able to generate tumors when injected blotting analysis (Supplemental Figure S2 at http://www.cancercell. subcutaneously into immunocompromised in mice ( Figure 4A o r g / c g i / c o nt e n t / f u l l / 2 / 5/ 401 / D C 1 ) . These results argue and Table 1 ). Tumors grew to a size at which the animals had against the possibility of selection for rare genetic events during to be sacrificed within a period of three to six weeks after tumor formation and support the notion that the combined exinjection, a latency comparable to that seen with control human pression of E1A, MDM2, and Ha-RasV12 is sufficient for the cancer cell lines or with transformed 293T cells ( Figure 4B ). transformation of normal human fibroblasts into tumor cells. Tumor formation was also observed when E1A was substituted by the C-terminal deletion mutant E1A-143 (data not shown).
Human fibroblasts transformed by E1A/MDM2/Ha-RasV12 Histological and immunohistochemical analyses of ERMlack telomerase activity derived tumors confirmed the human origin of the tumor cell Cell immortalization has been posited as a landmark occurrence population and indicated that the neoplasias have features of in the transformation of a normal cell into a cancer cell. Indeed, sarcoma. Moreover, immunohistochemistry confirmed the most human cancers are telomerase-positive, an indirect indication that these cells have acquired a mechanism for both telowidespread and strong expression of E1A, Ras, and MDM2 oncogenes ( Figure 4C ).
mere maintenance and extension of proliferative capacity (Kim et al., 1994) . In previous reports, transformation of normal huCell populations remained polyclonal throughout drug selection in vitro and tumorigenesis in vivo, as revealed by Southern man cells absolutely required activation of telomerase via ex- 
For each injection, 5 ϫ 10 6 cells of the indicated populations were injected subcutaneously in a volume of 100 l. Mice were sacrificed when the tumors reached a diameter of 1 to 1.2 cm or after 16 weeks of monitoring. The top and bottom portions of the table represent two independent series of experiments.
ized by dramatically reduced proliferation and adoption of a 
6A and 6B).
Tumors derived from E1A/MDM2/Ha-RasV12 lack telomerase activity pression of the limiting catalytic subunit, hTERT (Hahn et al., Since ERM-engineered fibroblasts were telomerase-negative at 1999; Elenbaas et al., 2001 , Hahn et al., 2002 . We previously the time of injection into mice, we were curious to ascertain the showed that E1A, Ha-RasV12, and MDM2 were individually telomerase status of resultant tumors and to determine whether incapable of activating telomerase in normal human fibroblasts telomerase activation was a requirement for tumorigenesis. Teor epithelial cells . We therefore tested the lomerase activity was measured utilizing the standard TRAP possibility that we had transformed normal human cells into assay described above on tissue sections obtained from the cancer cells in the absence of telomerase activation.
ERM tumors. Whereas a tissue sample from a human tumor Telomerase activity was easily detected in 293T cells using produced a robust signal indicative of telomerase activity in a the TRAP assay (Kim et al., 1994; Wright et al., 1995) . As few TRAP assay, lysates from ERM tumor tissues were telomeraseas ten 293T cells were capable of yielding a strong positive negative ( Figure 5B ). In order to verify that this negative result signal in our assays. As expected, BJ fibroblasts are telomerasewas not due to the presence of an inhibitory component within negative. We similarly fail to detect telomerase activity in BJ the tissue lysate, we performed a mixing experiment with lysate cells that have been engineered to express E1A, Ha-RasV12, from 293T cells. When the 293T cell and ERM tumor lysates were and MDM2 (BJ/ERM) ( Figure 5A ). We conclude that BJ/ERM mixed in a TRAP reaction, the result was positive, indicating that cells are telomerase-negative, or contain at least 1000-fold less there was no inhibitory component within the tumor lysate, and telomerase activity than do 293T cells at the time they are inthus the tumors were below detectable limits for telomerase jected into immunocompromised mice. activity ( Figure 5B ). It is interesting to note that BJ/ERM cells, although able to To verify the forgoing result, we used an independent experiform colonies in soft agar and tumors in nude mice, are not mental strategy. In human cells, and in particular in human immortal and, if maintained in culture for an extended period of time (40-50 generations), undergo a "crisis phase" characterfibroblasts such as BJ, telomerase activity correlates with the The TRAP assay was used to detect telomerase activity in uninfected BJ cells and BJ/ERM cells at various passages. At the time of injection (p20), ERM cells are telomerase-negative. However, after continuous passaging in culture, these cells undergo an event similar to crisis, a point at which many cells undergo apoptosis or senescence. Cells that emerged from this crisis event become telomerase-positive (ERM P.C.). The indicated protein concentrations (g) of S-100 extract were used. The highest protein concentration, 2.3 g, was also pretreated with RNase (R) as a negative control. B: Tumors were recovered from mice injected with BJ/ERM cells and assayed for the presence of telomerase activity using the TRAP assay. To test whether tissue extracts contained inhibitors of any step of the procedure, we mixed lysate derived from 1,000 telomerase-positive 293T cells with the tumor extract. This produced a positive signal. The figure shows one representative tumor sample. For comparison, a similar telomerase assay performed using a mass-equivalent portion of lysate from a human breast tumor is shown. C: RT-PCR was used to detect hTERT expression in BJ-ERM-derived tumors (tumors 1521, 1662, and 1659; left, sn Ϫ ; right, dx Ϫ ). Expression was tested by using two primer pairs that would direct the specific amplification of hTERT and not mouse TERT that might be present from contaminating murine cells within the tissue sample. ␤-actin served as an internal control. Sensitivity of the assay was increased by performing a Southern blot of the PCR reactions for hTERT. 293T, DLD colon cancer, and BL41 lymphoma cell lines were used as positive controls. 293T 1:100 represents the PCR product of 293T cell line diluted 1:100, in order to have an approximate quantification of the signal. The figure shows the result of 40 cycles of amplification for hTERT and 20 cycles for ␤-actin.
expression of the telomerase catalytic subunit, hTERT (Meyerpresent from contaminating murine cells in the tumor sample. son et al., 1997; Bodnar et al., 1998) . We used an RT-PCR ␤-actin mRNA served as an internal control. Ethidium bromide strategy to search for hTERT expression in BJ/ERM tumor specigel staining showed that hTERT mRNA was easily detectable mens. Expression was tested using two independent primer in RNA derived from human cancer cell lines, but BJ/ERM tupairs that were chosen for their ability to specifically amplify mors were negative ( Figure 5C ). To increase the sensitivity of human TERT without amplifying mouse TERT that might be our assay, we performed Southern blots of the PCR reactions. After Southern analysis, one out of six tumors analyzed, sample 1659sn, showed weak hTERT expression. This signal was detectable only with an exposure at which the signal of the positive control cells had reached saturation. The expression of hTERT in this tumor was independently confirmed by increasing the number of PCR cycles to 50 (see Figure 9B ). Considered together, these data suggest that BJ/ERM cells were competent for tumor formation in the absence of telomerase activity and that activation of telomerase can occur as a late event during tumor progression. Upon explantation into culture, BJ/ERM tumor cells, similar to late passage ERM, undergo a crisis event, which is marked by cellular senescence and apparent cell death. In contrast, explantation of tumors generated with 293T control cells did not produce a similar outcome. Instead, these cells proliferate robustly. Following this crisis event, few BJ/ERM tumor cells emerge to form a sustainable population. In contrast to early passage BJ/ERM cells and to BJ/ERM tumor samples, and similar to postcrisis late passage BJ/ERM, surviving tumor cells continuously passaged in culture until they underwent crisis (ERM P.C.).
In accord with this hypothesis, TRF assays and telomeric B: Telomere length in uninfected BJ, BJ/ERM, and ERM tumor explants were analyzed by TRF using pulse-field electrophoresis. As predicted, the telo- 
6B and 7). Telomeres in early passage BJ cells averaged ‫7ف‬
cell lines (1662dxp8, 1662snp18, and 1731snp9) had become extremely short irrespective of the fact they were telomerase-positive. kb in length. These became depleted as BJ cells were engi- 
A:
Telomere length distribution of BJ, BJ/ERM, and BJ/ERM tumor cells at different passages as determined by quantitative FISH (Q-FISH) using a fluorescent Cy-3 labeled telomeric peptide nucleic acid (PNA) probe. Average telomere length in kbps and standard deviation, as well as the total number of telomeres analyzed for each cell culture, are indicated. The percentage of undetectable telomeres using Q-FISH is also indicated. B: Representative Q-FISH images of metaphases from BJ, BJ/ERM, and BJ/ERM tumor cells hybridized with a telomeric PNA probe. We note a significant decrease in telomeric signal, as well as the increased chromosomal instability and increased aneuploidy in later passage ERM cells and in BJ/ERM tumorderived cells, 1662sn. Blue: DAPI; yellow dots: telomeres.
neered to express oncogenes and were passaged in vitro to an
The karyotypes of explanted BJ/ERM cells reveal chromosomal abnormalities characteristic average of 5 kb at passage 20 and 3.1 kb in BJ/ERM after crisis of telomere depletion occurred in vitro. Consistent with an apparent lack of a telomere As noted above, BJ cells are engineered to express E1A, Hamaintenance strategy, telomere depletion continued during tuRasV12, and MDM2 through simultaneous coinfection. Since mor formation in vivo such that explanted cell cultures had these cells have not undergone prolonged expansion in the extremely short telomeres, averaging 1.6 kb with 18% of chropresence of any individual oncogene in culture, it is not surprismosome ends lacking detectable telomeric DNA (Figure 7) . ing to find that the karyotypes of the engineered cells are normal These results rule out the possibility that BJ/ERM tumors have prior to injection into mice (Supplemental Figure S3A at http:// activated the recombination-based pathways of telomere mainwww.cancercell.org/cgi/content/full/2/5/401/DC1). Examinatenance (ALT) (Dunham et al., 2000;  tion of cells that are explanted into culture following tumor for- Hoare et al., 2001; . Interestingly, cells exmation, however, reveals numerous chromosomal abnormalities planted from ERM tumors that had become telomerase-positive (Figure 8 , Supplemental Table S2 , and Supplemental Figure in vitro ( Figure 6A ) maintained their ability to form tumors in S3B). In virtually every metaphase, we noted the presence of nude mice and did so at rates similar to those observed for dicentric chromosomes lacking telomeres at the fusion point that apparently formed via end-to-end fusion of TTAGGGprimary ERM cells (data not shown). depleted telomeres. In some metaphases, we also find ring pendent growth and tumor formation (see Experimental Procedures for details). In all the conditions tested, both early and chromosomes (Supplemental Figure S3B ). In addition, these cells showed a very marked aneuploidy as indicated by aberrant late passage BJ/ERM invariably produced colonies in soft agar and tumors in immunocompromised mice. number of chromosomes in more than 50% of the metaphases analyzed, also in agreement with aberrant mitosis as a conseFinally, to verify that E1A/MDM2/Ha-RasV12-mediated transformation is not unique to BJ fibroblasts, we assessed the quence of severe telomeric dysfunction (Figure 8 ). These types of genetic abnormalities are a characteristic outcome of telovalidity of our transformation model in several additional human primary fibroblasts, including HSF43, WI-38, Detroit 551, and mere depletion and are similar to those seen in the karyotypes of Terc Ϫ/Ϫ mice (Blasco et al., 1997b; Nanda et al., 1995) . Con-SF68 as well as in human primary mesodermal cells, HMSC. Upon coexpression of E1A/MDM2/Ha-RasV12, all were capable sidered together, the results of telomerase detection assays, telomere restriction fragment analyses, and cytogenetic examiof anchorage-independent growth in soft agar (not shown). Efficiencies of colony formation and rates of colony growth were nation of explanted tumor cells strongly suggest that combined expression of E1A, Ha-RasV12, and MDM2 is capable of transsimilar to those seen with BJ/ERM cells. Furthermore, these triple-infected fibroblasts were capable of tumor formation when forming normal human cells into human tumor cells in the absence of direct telomerase activation or alternative mechanisms injected into immunocompromised mice (Table 1 and Figure  9A ). Similar to BJ/ERM, HSF43/ERM, WI-38/ERM, and DET551/ of telomere maintenance.
ERM fibroblasts were telomerase-negative and the majority of the tumors derived from these cells failed to show telomerase Multiple human primary fibroblasts can be transformed by coexpression of E1A/MDM2/Ha-RasV12 expression by hTERT-RT-PCR analysis. Only 2 out of 8 tumors tested showed a faint hTERT band following 50 cycles of ampliIn order to ascertain whether the transforming potential of the ERM combination relied on the relatively long telomeres found fication ( Figure 9B ). This confirms that also in HSF43, WI-38, and DET551 fibroblasts, the ERM combination does not require in early passage BJ fibroblasts, populations of cells at different passage numbers were infected and tested for anchorage-indetelomerase activation to confer tumorigenic potential. 
Discussion
One striking difference between our results and those reported previously is that in our transformation model, we find Primary rodent cells and animal models have made invaluable no requirement for telomerase activation to achieve either ancontributions to our understanding of neoplastic transformation chorage-independent growth in vitro or tumor formation in vivo. and of the biology of oncogenes and tumor suppressors. HowIn fact, consistent with their lack of telomerase or other telomere ever, it is clear that these models do not perfectly recapitulate maintenance strategies, our in vitro-engineered tumor cells the process of tumor development in humans. An early indicashow continuous erosion of telomeric repeats. This ultimately tion of this fact was the inability of human cells to become leads to genetic instability that is typified by our observation of transformed by the same combinations of oncogenes that could numerous chromosome end-to-end fusions and pronounced transform a variety of normal rodent cells. Recently, the ability aneuploidy in cells explanted from tumor tissue. to elicit transformation via specific genetic manipulations was
The majority of human cancer cells are reported to be teloextended to normal human cells (Hahn et al., 1999 ; Elenbaas merase-positive (Kim et al., 1994) , and this is long been considet al., 2001 considet al., , Hahn et al., 2002 . This has created the opportunity ered a strong indication that the ability to maintain telomeres for the development of a variety of defined human cancer modis an important step in the development of human cancer. Howels to be used for a detailed study of the cellular pathways that ever, it is still debated whether the widespread presence teloare required for the transformation of normal human cells, and merase activity in human tumors is a reflection of a selective ultimately, to an understanding of any differences in requireexpansion of a telomerase-positive stem cell or a selection for ments for the transformation of human cells versus those of a mechanism of telomere maintenance during cancer promodel organisms. Such information could provide critical ingression. sights as rationally designed anticancer therapies move from Our results are consistent with a model in which telomere successful applications in animal models to use in humans.
maintenance is not essential for transformation, per se, but Here we report that primary human fibroblasts can be transinstead serves as a catalyst of tumorigenic conversion and tumor progression. Mouse models have shown that alterations in formed into cancer cells by combined expression of the adenovirus E1A, Ha-RasV12, and MDM2. As in previous models of telomere biology may contribute to tumorigenesis in two ways. We and others have previously reported that telomere shortenhuman cell transformation, we make use of a combination of viral and cellular oncoproteins that act in a transdominant fashion to ing triggers growth arrest and/or apoptosis, as well as chromosomal end-to-end fusions, leading to premature aging phenoalter cellular physiology and achieve tumorigenic growth. In accord with previous reports, we show that transformation retypes in the context of the telomerase-deficient mice. These phenotypes can be rescued by telomerase activation (Lee et quires negation of both the Rb and p53 tumor suppressor pathways. Through genetic analyses, we have also identified requireal., 1998; Herrera et al., 1999 Herrera et al., , 2000 Samper et al., 2001 ). Thus, telomere shortening during the presumably prolonged course ments for interaction with p300 and p400. Both of these cellular proteins are also targeted by SV40 large T-antigen, which is a of natural tumor development may antagonize tumorigenesis. Indeed, Terc Ϫ/Ϫ mice are more resistant to chemical carcinogencritical element of the transformation model reported by Weinberg and colleagues (Hahn et al., 1999; Elenbaas et al., 2001) . esis and to spontaneous tumor development in both p16/ p19ARF and APC min mutant backgrounds (Greenberg et al., However, recent reports suggest that these are not critical functions of large T, at least in the presence of small t-antigen (Hahn 1999; Gonzá lez-Suá rez et al., 2000; Rudolph et al., 2001 higher levels of chromosomal instability and a higher incidence WI-38 are normal embryonic lung fibroblasts (ATCC catalog CCL-75).
of cancer, suggesting that telomere depletion can actually act
These cells have a finite lifespan of 50 Ϯ 10 PD and were provided by ATCC as a prooncogenic factor under certain conditions (Chin et al., at PD24. These cells were infected at passage 6 and 10 and injected into 1999).
mice at passage 14, 15, and 18. Detroit 551 are normal human fetal fibroblasts The data presented here suggest that, while changes in provided by ATCC around PD 10 and reported to have a finite lifespan of telomere biology are very likely to be important for the course 25 additional serial passages. These cells were infected at passage 6 and of natural tumor development, telomere maintenance is not an 10 and injected into mice at passage 14-15 and 18.
absolute requirement for the creation of human cancer cells by HSF43 are normal human foreskin fibroblasts originally isolated at the acute alteration of oncogenes and tumor suppressors. Rather, Los Alamos National Laboratory. The original PD of these cells was unknown in our human transformation model, the activation of telomere but in our hands they cease proliferation after 40-50 passages. These cells were infected at passage 17 and 20 and injected at passage 24 and 27.
maintenance strategies becomes important only during pro-HS68 are normal human foreskin fibroblasts (ATCC catalog CRL-1635) longed expansion of tumor cells to restore genomic stability to that were received from ATCC at PD 16. These cells can be propagated for an extent that permits cell survival. Our data are in agreement 40-50 passages. They were infected at passage 11 and 17.
with observations in a number of human cancers where the HMSC 7214 are normal human mesenchymal stem cells obtained from frequency and intensity of telomerase activation correlates with
Poietics-Biowhittaker at passage 2 (catalog PT-2501). They were derived tumor grade/stage (Chadeneau et al., 1995; Hiyama et al., 1995;  from a 19-year-old Caucasian male and their lifespan has not been determined. These cells were infected at passage 6. Albanell et al., 1997; Tang et al., 1998; Ebina et al., 1999; Yan et al., 1999) . Indeed, our ERM system can be considered as a maintained at a subcultivation ratio of 1:2 every 3 days.
Using oncoprotein mutants and genetic complementation,
Retroviral infection
we find that inactivation of the Rb and p53 tumor suppressor pBABE-Puro Ha-rasV12, Wzl-Neo E1A 12s, pHygroMaRX mdm2, and correpathways is critical for this transformation process. Furthersponding empty retroviral vectors were used to singularly transfect the ammore, we find that the ability of E1A to target p300 and p400
photropic packaging cell line LinX-A (Hannon et al., 1999) . Transfection was is essential for its ability to function as a human oncogene. It performed by the calcium phosphate method. At 72 hr posttransfection, will also be of interest to determine whether MDM2 contributes viral supernatants were collected, filtered, supplemented with 4 g/ml polyto the transformation of human cells solely through its ability brene, and combined in order to obtain the oncogene combinations described in the text. In cells where only one or two oncogenes were used to to antagonize p53 or also via effects on additional cellular pathinfect the primary cells, corresponding empty vectors replaced the omitted ways.
oncogenes so that infected cells were equally resistant to all the selection
The war on cancer is predicated on the notion that increased drugs used (hygromycin, puromycin, and neomycin). The proper viral mix understanding of the biology of cancer cells might reveal an was then used to infect human primary fibroblasts (BJ, Detroit 551, WI-38, "Achilles heel" that can be exploited as an effective and specific HSF43, SF68) and human primary mesodermal cells (HMSC). After infection, therapeutic target. The use of rodent cell culture and of animal cells were selected with a combination of hygromycin (50 g/ml), puromycin (1 g/ml), and neomycin (300 g/ml) for 7 days. Effective infection was models have been the most informative vehicles in the drive confirmed by Western blot analysis.
toward this goal. However, the availability of defined human cell transformation models will allow us to build toward a complete
Western blot analysis
understanding of the biological pathways that must be altered
Western blotting was performed essentially as described by Harlow and to achieve tumorigenic conversion of normal cells. Lane (1999) . Cells were washed with cold PBS and lysed in Laemmli loading buffer. Lysates were heated at 95ЊC for 10 min. Samples were separated on Experimental procedures 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher & Schuell) . Blots were incubated with the following mouse monoCells clonal antibodies: E1A-specific M58 and M73 antibody-the latter recogThe following human primary cells were used for the experiments described nizes an epitope retained in all E1A mutants studied (Samuelson and Lowe, in the text. We defined passage number 1 as the passage at which the cells 1997); c-Ha-ras (OP23) (Oncogene Research Products); mdm2-spcific antiwere provided from ATCC. All the cells were maintained at a subcultivation body (4B2) (a kind gift from A. Levine); bcl2 (C2) (Santa Cruz); p53 (DO-1) ratio of 1:2 every 3 days.
(Santa Cruz). Immune complexes were visualized by secondary incubation BJ are normal human foreskin fibroblasts (ATCC catalog CRL-2522) .
with a sheep anti-mouse HRP-conjugated secondary antibody (Amersham). They were provided by ATCC at population doubling 22 and are described Blots were developed by enhanced chemiluminescence (Amersham). to have the capacity to reach 80 Ϯ 10 PD. In our hands, these cells cease proliferation at around passage 45. Most of the experiments described in Anchorage-independent growth the text were done using BJ infected at passage 16 and injected at passages Human primary fibroblasts uninfected, infected with a control empty virus, 20, 25, and 30. However, experiments were also performed at earlier and or expressing different oncogenes (E1A, Ha-rasV12, mdm2), alone or in later passages. In particular, BJ cells were infected at passage 8, 16, and combination, were analyzed for anchorage-independent growth in semisolid media. Approximately 10 5 cells were plated in 0.3% low melting point aga-22. Cells infected at passage 8 were injected into mice at passage 12 and 20. rose/growth media onto 60 mm dishes with a 0.5% agarose underlay. Fresh Images were captured using Leica Q-FISH software at 400 mSec intetop agar was added weekly. Colonies were photographed after 2 weeks.
gration-time in a linear acquisition mode to prevent oversaturation of fluorescence intensity and recorded using a COHU CCD camera on a Leica Leitz DMRB fluorescence microscope. Subcutaneous tumorigenicity assay For the tumorigenicity assays, eight-week-old immunocompromised TFL-Telo software (gift from Dr. Lansdorp, Vancouver) was used to athymic nude mice (Hsd:Athymic nude-nu, Harlan) were used. Cells (5 ϫ quantify the fluorescence intensity of telomeres from at least 10 metaphases 10 6 ) were resuspended in 100 l of PBS and injected with a 25 gauge needle of each data point. The images of metaphases from different cell cultures into anaesthetized mice.
were captured on the same day in parallel, and scored blind. BJ cells infected with the E1A/ras combination were also injected into
Terminal restriction fragment analysis (TRF) 10 nude mice ␥-irradiated with 400 rad prior injection and into 6 SCID beige Cells were prepared in agarose plugs and digested with Mbo I for TRF mice (C.B-17/lcrHsd-scid-bg, Harlan). Tumor size was monitored every 5 analysis using pulse-field electrophoresis as described in Blasco et al. days. Mice were sacrificed when the tumors reached a diameter of 1-1.2 (1997b). cm or after 16 weeks of monitoring.
Telomerase assays Tumors were collected in a sterile field and minced. Tumor fragments Telomerase activity was measured with a modified telomeric repeat amplifiwere immediately frozen in liquid nitrogen for DNA and protein extraction cation protocol (TRAP), as described (Blasco et al., 1997b) . and for telomerase assays. Other fragments were fixed in 10% formalin for histological and immunohistochemical examinations. Finally, fragments were Analysis of hTERT mRNA expression by RT-PCR finely minced, washed in PBS, and plated in culture medium for isolation of Analysis of human TERT expression was carried out by RT-PCR. cDNA was tumor cells.
synthesized from 1 g of total RNA using random primers in a 20 l reaction. 1 l of cDNA was then used to amplify two fragments of human TERT Tumor morphological and histochemical examination sequence, both spanning an intronic sequence. Primers hTERT1s, 5Ј-TTCCT Formalin-fixed/paraffin-embedded or snap-frozen fragments of tumor speci-GCACTGGCTGATGAGTGT-3Ј and hTERT1a, 5Ј-AGCGTCGGCCCTCTTTTC mens were stained with hematoxylin and eosin and with histochemical stains TCTG-3Ј were used to amplify a 330 bp fragment spanning exons 3 and 4 (PAS and PAS after diastase, Reticulum, and Masson's trichrome stain) for of the human TERT sequence. Primers hTERT2s, 5Ј-ACAGCACTTGAA morphological evaluation and histochemical analyses. Immunohistochemis-GAGGGTG-3Ј and hTERT2a, 5Ј-GTGCCTTCACCCTCGAGG-3Ј were used try was performed with the peroxidase ARK kit (DAKO Glostrup Denmark) to amplify a 210 bp fragment spanning exons 4 and 5 of the human TERT and DAB as chromogen. The following primary antibodies were utilized:
sequence. Both PCR reactions were carried out for 40 or 50 cycles with an Intermediate filaments (Vimentin, pan-keratin, desmin) and other human speelongation at 72ЊC for 30 s and annealing at 65ЊC. PCR products were cific monoclonal antibodies (S100 protein, EMA, CD45) were used as histoanalyzed on a 3% agarose gel. The quality of cDNA was controlled by PCR genetic markers. The expression of ectopically expressed oncogenes was amplification of a 500 bp fragment of a ␤-actin transcript in a 20 cycle-PCR determined by using monoclonal antibodies specific for MDM2 (4B2) (a kind reaction. gift from A. Levine), p21-ras (OP23) (Oncogene Research Products), and E1A (M73). Acknowledgments
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Membranes were washed twice in 0.1% SDS, 0.2ϫ SSC and once in 0.1ϫ SSC at 60ЊC, followed by autoradiography.
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